Russell D. Cohen to Biosimilar Pharmaceuticals
This is a "connection" page, showing publications Russell D. Cohen has written about Biosimilar Pharmaceuticals.
Connection Strength
0.186
-
Efficacy of biosimilar infliximab CT-P13 among inpatients with severe steroid-refractory colitis. Int J Colorectal Dis. 2020 Nov; 35(11):2113-2116.
Score: 0.186
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.